Sign In
Buy SYK
$337.03
+1.07 (+0.318%)
At Close: Aug 05, 2026
Stryker (SYK) Q1 Earnings Beat Estimates, Volume Improves
08:25am, Tuesday, 02'nd May 2023
Stryker's (SYK) first-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.
Stryker Corporation (SYK) Q1 2023 Earnings Call Transcript
09:07pm, Monday, 01'st May 2023
Stryker Corporation (NYSE:SYK ) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Jason Beach - Vice President, Investor Relat
Stryker (SYK) Tops Q1 Earnings and Revenue Estimates
07:01pm, Monday, 01'st May 2023
Stryker (SYK) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $1.97 per share a year ago.
3 Medical Device Stocks Outpacing the Healthcare Industry This Year
06:30am, Monday, 01'st May 2023
Medtronic has raised its dividend for 45 consecutive years. Edwards Lifesciences had a strong first quarter and upgraded 2023 guidance.
These 3 Stocks Might Be Getting a Little Too Expensive
07:00am, Sunday, 30'th Apr 2023
Shares of candy maker Hershey have gained for a decade at a double-digit percentage rate. Stryker is a diversified healthcare specialist with a promising future.
Stryker: Consistently Innovative With Steady Profits And Dividends
11:42pm, Saturday, 29'th Apr 2023
Stryker operates in the medical sector and is engaged in the innovation and sale of medical equipment internationally. SYK has new offerings that partially contributed to its revenues.
Earn Double-Digit Income With Options (May 2023)
09:00am, Saturday, 29'th Apr 2023
We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate an options income strategy that's sustainable and rep
3 Reasons To Consider Buying Stryker Corporation
03:25pm, Thursday, 27'th Apr 2023
Stryker Corporation's innovative surgical solutions position the company to capitalize on the growing demand for joint replacement technology.
Healthcare Innovation Drives Medical Device Makers To New Highs
08:16am, Monday, 17'th Apr 2023
The healthcare sector has been looking fit in the past month, with medical products makers Stryker Corp. (NYSE: SYK) and Boston Scientific Corp. (NYSE: BSX) rallying to all-time highs, while sector pe
HAE vs. SYK: Which Stock Is the Better Value Option?
12:55pm, Friday, 14'th Apr 2023
Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their b
Stryker (SYK) is a Great Momentum Stock: Should You Buy?
01:02pm, Tuesday, 11'th Apr 2023
Does Stryker (SYK) have what it takes to be a top stock pick for momentum investors? Let's find out.
2 Top Stocks to Buy in April and Hold Forever
07:39am, Saturday, 08'th Apr 2023
Bristol Myers Squibb and Stryker are both developing life-changing products for patients. The two companies each pay growing dividends to shareholders.
Here's Why You Should Add Stryker (SYK) Stock to Your Portfolio
12:14pm, Thursday, 06'th Apr 2023
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the company.
Stryker to announce financial results for its first quarter of fiscal year 2023
04:05pm, Thursday, 30'th Mar 2023
Kalamazoo, Michigan, March 30, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2023 on Monday, May 1, 2023. A press relea
Investment in procedural medical devices is safer for valuation, says E Squared's Les Funtleyder
02:12pm, Thursday, 30'th Mar 2023
Les Funtleyder, portfolio manager for E Squared Capital Management, joins 'The Exchange' to discuss big cap pharma's Q1 performance, the dollar weakness contributing to biotech gains, and investment o
